课题基金 / 基金详情

The roles of vascular permeability factor/vascular endothelial growth factor in mesangial proliferative glomerulonephritis

The roles of vascular permeability factor/vascular endothelial growth factor in mesangial proliferative glomerulonephritis
血管通透因子/血管内皮生长因子在系膜增生性肾小球肾炎中的作用
批准号:
08671286
负责人:
IIJIMA Kazumoto
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

IIJIMA Kazumoto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a multifunctional cytokine involved in angiogenesis, inflammation and wound healing. VPF/VEGF has been reported to be produced only by glomerular podocytes in glomeruli and we found that it si produced by human cultured mesangial cells (MC). Therefore, we performed immunohistochemical analysis, using indirect immunofluorescence and in situ hybridization, of VPF/VEGF in normal kidneys (n=7) and biopsy specimens taken from 83 patients with renal diseases, including mesangial proliferative glomerulonephritis (PGN,n=58), to examine whether VPF/VEGF is produced by MC in human PGN.In all the normal subjects and all the patients except those with PGN (disease controls), VPF/VEGF protein and mRNA were detected mainly in podocytes, indicating that VPF/VEGF was produced mainly by podocytes. However, in some PGN patients, VPF/VEGF protein was demonstrated clearly in MC as well as in podocytes, as some … More of the VPF/VEGF was co-localized with alpha-smooth muscle actin, a marker of activated MC,and VPF/VEGF mRNA was expressed by MC and podocytes. Mesangial VPF/VEGF expression in PGN patients with early lesions (predominant mesangial hypercellularity) was enhanced significantly compared with that in those with later lesions (similar degree of mesangial hypercellularity and increased matrix, p<0.01, or predominant mesangial matrix increase, p<0.05), that in disease controls and normal subjects (both p<0.01). The time between biopsy and disease onset was significantly shorter in PGN patients with than without mesangial VPF/VEGF expression (p<0.01). These findings provide the first evidence that activated MC are a source of VPF/VEGF in human PGN,and indicate that mesamgial VPF/VEGF expression is characteristic of early lesions of PGN.As VPF/VEGF plays a pivotal role in tissue repair, MC-produced VPF/VEGF may play pathophysiological roles, including promoting recovery from glomerular injuries, in early-stage PGN. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
飯島 一誠 他: "活性化メサンギウム細胞による血管透過性亢進因子(VPF/VEGF)の産生とその病態生理学的意義" 日本小児腎臓病学会雑誌. 10(1). 22-25 (1997)
Kazumasa Iijima 等人:“活化的系膜细胞产生血管通透性增强因子 (VPF/VEGF) 及其病理生理学意义”,日本小儿肾脏病学会杂志 10(1) (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
飯島一誠他: "活性化メサンギウム細胞による血管透過性亢進因子(VPF/VEGF)の産生とその病態生理学的意義" 日本小児腎臓病学会雑誌. 10(1). 22-25 (1997)
Kazumasa Iijima 等人:“活化的系膜细胞产生血管通透性增强因子 (VPF/VEGF) 及其病理生理学意义”,日本小儿肾脏病学会杂志 10(1) (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    New responsible genes for CAKUT and development of comprehensive gene mutation detection system in CAKUT
    • 批准号:
      23591192
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      IIJIMA Kazumoto
    • 依托单位:
    Identification of novel genes for congenital anomalies of Kidney and urinary tract (CAKUT) by CNV analyses and development of comprehensive gene testing for CAKUT
    • 批准号:
      20390240
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2008
    • 负责人:
      IIJIMA Kazumoto
    • 依托单位:
    Analysis of familial steroid-sensitive nephrotic syndrome
    海外基金